338 related articles for article (PubMed ID: 9672212)
1. Evaluation of cytomegalovirus retinitis management. Outcome of four years of cytomegalovirus therapy.
Ries E; Mühlbauer B; Ruhswurm I; Krepler K; Derbolav A; Svolba G; Rieger A; Wedrich A
Ophthalmologica; 1998; 212(4):239-43. PubMed ID: 9672212
[TBL] [Abstract][Full Text] [Related]
2. Combination foscarnet and ganciclovir therapy vs monotherapy for the treatment of relapsed cytomegalovirus retinitis in patients with AIDS. The Cytomegalovirus Retreatment Trial. The Studies of Ocular Complications of AIDS Research Group in Collaboration with the AIDS Clinical Trials Group.
Arch Ophthalmol; 1996 Jan; 114(1):23-33. PubMed ID: 8540847
[TBL] [Abstract][Full Text] [Related]
3. Combined intravenous ganciclovir and foscarnet for children with recurrent cytomegalovirus retinitis.
Walton RC; Whitcup SM; Mueller BU; Lewis LL; Pizzo PA; Nussenblatt RB
Ophthalmology; 1995 Dec; 102(12):1865-70. PubMed ID: 9098289
[TBL] [Abstract][Full Text] [Related]
4. Rhegmatogenous retinal detachment in patients with cytomegalovirus retinitis: the Foscarnet-Ganciclovir Cytomegalovirus Retinitis Trial. The Studies of Ocular Complications of AIDS (SOCA) Research Group in Collaboration with the AIDS Clinical Trials Group (ACTG).
Am J Ophthalmol; 1997 Jul; 124(1):61-70. PubMed ID: 9222234
[TBL] [Abstract][Full Text] [Related]
5. Cytomegalovirus retinitis: diagnosis and status of systemic therapy.
Friedberg DN
J Acquir Immune Defic Syndr Hum Retrovirol; 1997; 14 Suppl 1():S1-6. PubMed ID: 9058611
[TBL] [Abstract][Full Text] [Related]
6. Cytomegalovirus retinitis and viral resistance. Prevalence of resistance at diagnosis, 1994. Cytomegalovirus Retinitis and Viral Resistance Study Group.
Jabs DA; Dunn JP; Enger C; Forman M; Bressler N; Charache P
Arch Ophthalmol; 1996 Jul; 114(7):809-14. PubMed ID: 8660163
[TBL] [Abstract][Full Text] [Related]
7. Therapy with a combination of intravitreal foscarnet and intravenous ganciclovir in clinically resistant cytomegalovirus retinitis and patients with acquired immunodeficiency syndrome.
Guembel HO; Hofmann F; van Even G; Cinatl J; Makabe R
Ger J Ophthalmol; 1996 Nov; 5(6):490-1. PubMed ID: 9479542
[No Abstract] [Full Text] [Related]
8. Long-lasting remission of cytomegalovirus retinitis without maintenance therapy in human immunodeficiency virus-infected patients.
Tural C; Romeu J; Sirera G; Andreu D; Conejero M; Ruiz S; Jou A; Bonjoch A; Ruiz L; Arnó A; Clotet B
J Infect Dis; 1998 Apr; 177(4):1080-3. PubMed ID: 9534987
[TBL] [Abstract][Full Text] [Related]
9. [Foscarnet for cytomegalovirus retinitis in a patient with acquired immunodeficiency syndrome].
Nagata Y; Fujino Y; Ono A; Mochizuki M; Mouri H; Oka S; Kimura S; Shimada K
Nippon Ganka Gakkai Zasshi; 1994 Jul; 98(7):710-5. PubMed ID: 8067306
[TBL] [Abstract][Full Text] [Related]
10. Viral sensitivity testing in patients with cytomegalovirus retinitis clinically resistant to foscarnet or ganciclovir.
Dunn JP; MacCumber MW; Forman MS; Charache P; Apuzzo L; Jabs DA
Am J Ophthalmol; 1995 May; 119(5):587-96. PubMed ID: 7733184
[TBL] [Abstract][Full Text] [Related]
11. Cytomegalovirus (CMV) culture results, drug resistance, and clinical outcome in patients with AIDS and CMV retinitis treated with foscarnet or ganciclovir. Studies of Ocular Complications of AIDS (SOCA) in collaboration with the AIDS Clinical Trial Group.
J Infect Dis; 1997 Jul; 176(1):50-8. PubMed ID: 9207349
[TBL] [Abstract][Full Text] [Related]
12. Identification and treatment of cytomegalovirus retinitis in patients with AIDS.
Speyrer MP
J Am Acad Nurse Pract; 1997 Jul; 9(7):329-31. PubMed ID: 9274255
[No Abstract] [Full Text] [Related]
13. Treatment of clinically resistant cytomegalovirus retinitis with combined intravitreal injections of ganciclovir and foscarnet.
Desatnik HR; Foster RE; Lowder CY
Am J Ophthalmol; 1996 Jul; 122(1):121-3. PubMed ID: 8659587
[TBL] [Abstract][Full Text] [Related]
14. Controversies in the treatment of cytomegalovirus retinitis: foscarnet versus ganciclovir.
Jabs DA
Infect Agents Dis; 1995 Sep; 4(3):131-42. PubMed ID: 8548191
[TBL] [Abstract][Full Text] [Related]
15. New treatment options for CMV retinitis in AIDS.
Lalezari JP
Adv Nurse Pract; 1997 Apr; 5(4):45-9, 83. PubMed ID: 9459896
[No Abstract] [Full Text] [Related]
16. Foscarnet-Ganciclovir Cytomegalovirus Retinitis Trial. 4. Visual outcomes. Studies of Ocular Complications of AIDS Research Group in collaboration with the AIDS Clinical Trials Group.
Ophthalmology; 1994 Jul; 101(7):1250-61. PubMed ID: 8035989
[TBL] [Abstract][Full Text] [Related]
17. Combination ganciclovir and foscarnet in the treatment of clinically resistant cytomegalovirus retinitis in patients with acquired immunodeficiency syndrome.
Kuppermann BD; Flores-Aguilar M; Quiceno JI; Rickman LS; Freeman WR
Arch Ophthalmol; 1993 Oct; 111(10):1359-66. PubMed ID: 8216016
[TBL] [Abstract][Full Text] [Related]
18. Survival differences associated with treatment of cytomegalovirus retinitis in Maryland patients with AIDS, 1987-1994.
Wutoh AK; Hidalgo J; Rhee W; Bareta J; Steidl S
Am J Health Syst Pharm; 1999 Jul; 56(13):1314-8. PubMed ID: 10683128
[TBL] [Abstract][Full Text] [Related]
19. Re-evaluation of time to progression of foscarnet salvage therapy for cytomegalovirus retinitis in AIDS patients clinically resistant to ganciclovir.
Mueller AJ; Jacobson MA; Hurwitz S; Chuang EL; Friedberg DN; Haidt SJ; Heinemann MH; Jabs DA; Kaplan HJ; Freeman WR
AIDS; 1997 Mar; 11(3):397-9. PubMed ID: 9147441
[No Abstract] [Full Text] [Related]
20. Therapeutic options for resistant cytomegalovirus retinitis.
Kuppermann BD
J Acquir Immune Defic Syndr Hum Retrovirol; 1997; 14 Suppl 1():S13-21. PubMed ID: 9058613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
